Author: uptick-admin
-
Three Top Obesity Drug Stocks that Could See Higher Highs
The obesity treatment market is explosive. Look at Eli Lilly (LLY), for example. The stock exploded from about $460 to a high of $782 just over excitement with its obesity treatment. It also just blew earnings out of the water, thanks in part to obesity drug sales. In fact, sales of its Zepbound treatment rocketed…
-
Three of the Biggest Losers Could be Among the Biggest Winners in 2024
Some of the year’s biggest losers could be among next year’s biggest winners. Look at illumina (ILMN), for example. Down about 30% on the year, Illumina dealt with quite a bit of chaos. However, after missing earnings, cutting guidance, being fined by the European Union, removing its CEO, CFO, and CTO, and finally divesting its…
-
Top Ways to Trade the Biotech M&A Boom
Some of the most explosive opportunities can be found in biotech. For one, the sector is still one of the safest, most recession-proof investments around. Two, an aging population is demanding better treatment in an effort to live longer lives. Three, there’s incredible new innovation in gene therapies, weight loss, immuno-oncology, precision medicine, machine-learning…